Amgen Inc SEC filings AMGN

Amgen Inc has 1,000 filings in SEC EDGAR's recent list, going back to May 22, 2018. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

Amgen Inc SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 3, 2026 Nov 3, 2026
8-K Current report
Officer or director change
Oct 27, 2026 Oct 26, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 4, 2026 Aug 4, 2026
8-K Current report Jul 31, 2026 Jul 29, 2026
11-K Employee savings plan report Jun 11, 2026 Dec 31, 2025
11-K Employee savings plan report Jun 11, 2026 Dec 31, 2025
8-K Current report
Shareholder vote results
May 20, 2026 May 19, 2026
8-K Current report
Officer or director change
May 19, 2026 May 19, 2026
10-Q Quarterly report May 1, 2026 Mar 31, 2026
8-K Current report
Results of operations
Apr 30, 2026 Apr 30, 2026
8-K Current report
Officer or director change
Apr 22, 2026 Apr 22, 2026
DEFA14A Additional proxy material Apr 21, 2026 —
DEFA14A Additional proxy material Apr 15, 2026 —
DEFA14A Additional proxy material Apr 7, 2026 —
DEF 14A Proxy statement Apr 7, 2026 May 19, 2026
ARS Annual report to shareholders Mar 31, 2026 Dec 31, 2025
25-NSE Delisting notice Feb 24, 2026 —
8-K Current report
Material agreement
Feb 19, 2026 Feb 17, 2026
424B2 Prospectus Feb 19, 2026 —
FWP Free writing prospectus Feb 17, 2026 —
424B3 Prospectus Feb 17, 2026 —
S-3ASR Automatic shelf registration Feb 13, 2026 —
10-K Annual report Feb 13, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 3, 2026 Feb 3, 2026
8-K Current report
Agreement ended
Jan 30, 2026 Jan 30, 2026
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
11-K Employee savings plan report Jun 12, 2025 Dec 31, 2024
11-K Employee savings plan report Jun 12, 2025 Dec 31, 2024
8-K Current report
Shareholder vote results
May 27, 2025 May 23, 2025
10-Q Quarterly report May 2, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 1, 2025 May 1, 2025
DEFA14A Additional proxy material Apr 29, 2025 —
DEFA14A Additional proxy material Apr 17, 2025 —
PX14A6G Filing Apr 16, 2025 —
DEFA14A Additional proxy material Apr 9, 2025 —
DEF 14A Proxy statement Apr 9, 2025 May 23, 2025
ARS Annual report to shareholders Apr 2, 2025 Dec 31, 2024
10-K Annual report Feb 14, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 4, 2025 Feb 4, 2025
10-Q Quarterly report Oct 31, 2024 Sep 30, 2024
8-K Current report
Results of operations
Oct 30, 2024 Oct 30, 2024
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
11-K Employee savings plan report Jun 21, 2024 Dec 31, 2023
11-K Employee savings plan report Jun 21, 2024 Dec 31, 2023
S-8 Employee stock plan registration Jun 12, 2024 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 3, 2024 May 31, 2024
DEFA14A Additional proxy material May 10, 2024 —
UPLOAD Letter from the SEC May 10, 2024 —
DEFA14A Additional proxy material May 3, 2024 —
10-Q Quarterly report May 3, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 2, 2024 May 2, 2024
DEFA14A Additional proxy material Apr 26, 2024 —
CORRESP Letter to the SEC Apr 22, 2024 —
DEFA14A Additional proxy material Apr 17, 2024 —
DEF 14A Proxy statement Apr 17, 2024 May 31, 2024
ARS Annual report to shareholders Apr 10, 2024 Dec 31, 2023
UPLOAD Letter from the SEC Apr 5, 2024 —
10-K Annual report Feb 14, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 6, 2024 Feb 6, 2024
8-K Current report
Officer or director change
Dec 14, 2023 Dec 12, 2023
10-Q Quarterly report Oct 31, 2023 Sep 30, 2023
8-K Current report
Results of operations
Oct 31, 2023 Oct 31, 2023
S-8 Employee stock plan registration Oct 6, 2023 —
8-K Current report
Acquisition or sale of assets, New debt, Regulation FD disclosure
Oct 6, 2023 Oct 6, 2023
8-K Current report
Other events
Oct 5, 2023 Oct 5, 2023
8-K Current report
Other events
Sep 12, 2023 Sep 11, 2023
8-K Current report
Other events
Sep 5, 2023 Sep 1, 2023
8-K Current report
Regulation FD disclosure, Other events
Sep 1, 2023 Sep 1, 2023
10-Q Quarterly report Aug 4, 2023 Jun 30, 2023
8-K Current report
Officer or director change
Aug 4, 2023 Aug 1, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
11-K Employee savings plan report Jun 15, 2023 Dec 31, 2022
11-K Employee savings plan report Jun 15, 2023 Dec 31, 2022
8-K Current report
Other events
Jun 5, 2023 Jun 2, 2023
8-K Current report
Shareholder vote results
May 22, 2023 May 19, 2023
8-K Current report
Other events
May 18, 2023 May 17, 2023
8-K Current report
Regulation FD disclosure
May 16, 2023 May 16, 2023
DEFA14A Additional proxy material May 3, 2023 —
10-Q Quarterly report Apr 28, 2023 Mar 31, 2023
8-K Current report
Results of operations
Apr 27, 2023 Apr 27, 2023
DEFA14A Additional proxy material Apr 25, 2023 —
DEFA14A Additional proxy material Apr 14, 2023 —
DEFA14A Additional proxy material Apr 6, 2023 —
DEF 14A Proxy statement Apr 6, 2023 —
ARS Annual report to shareholders Mar 30, 2023 Dec 31, 2022
8-K Current report
Material agreement, Agreement ended
Mar 9, 2023 Mar 9, 2023
8-K Current report
Material agreement
Mar 2, 2023 Mar 2, 2023
424B2 Prospectus Feb 17, 2023 —
8-K Current report
Material agreement
Feb 16, 2023 Feb 15, 2023
FWP Free writing prospectus Feb 16, 2023 —
424B3 Prospectus Feb 14, 2023 —
S-3ASR Automatic shelf registration Feb 9, 2023 —
10-K Annual report Feb 9, 2023 Dec 31, 2022
8-K Current report
Material agreement, Results of operations, Other events
Jan 31, 2023 Jan 30, 2023
8-K Current report
Material agreement, New debt
Dec 22, 2022 Dec 22, 2022
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Dec 12, 2022 Dec 11, 2022
8-K Current report
Regulation FD disclosure
Dec 2, 2022 Dec 2, 2022
10-Q Quarterly report Nov 4, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
8-K Current report
Regulation FD disclosure
Oct 20, 2022 Oct 20, 2022
8-K Current report
Material agreement
Aug 18, 2022 Aug 15, 2022
424B2 Prospectus Aug 16, 2022 —
FWP Free writing prospectus Aug 15, 2022 —
424B3 Prospectus Aug 15, 2022 —
10-Q Quarterly report Aug 5, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
8-K Current report
Material agreement, Regulation FD disclosure
Aug 4, 2022 Aug 3, 2022
8-K Current report
Officer or director change
Aug 3, 2022 Aug 3, 2022
11-K Employee savings plan report Jun 24, 2022 Dec 31, 2021
11-K Employee savings plan report Jun 24, 2022 Dec 31, 2021
8-K Current report
Shareholder vote results
May 18, 2022 May 17, 2022
DEFA14A Additional proxy material Apr 28, 2022 —
10-Q Quarterly report Apr 28, 2022 Mar 31, 2022
8-K Current report
Results of operations
Apr 27, 2022 Apr 27, 2022
DEFA14A Additional proxy material Apr 22, 2022 —
DEFA14A Additional proxy material Apr 13, 2022 —
DEFA14A Additional proxy material Apr 5, 2022 —
DEF 14A Proxy statement Apr 5, 2022 May 17, 2022
8-K Current report
Material agreement
Feb 25, 2022 Feb 24, 2022
8-K Current report
Material agreement
Feb 22, 2022 Feb 17, 2022
424B2 Prospectus Feb 18, 2022 —
FWP Free writing prospectus Feb 17, 2022 —
424B3 Prospectus Feb 17, 2022 —
10-K Annual report Feb 16, 2022 Dec 31, 2021
25-NSE Delisting notice Feb 7, 2022 —
8-K Current report
Results of operations
Feb 7, 2022 Feb 7, 2022
8-K Current report
Material agreement, Agreement ended
Jan 31, 2022 Jan 31, 2022
S-8 Employee stock plan registration Nov 3, 2021 —
S-8 Employee stock plan registration Nov 3, 2021 —
10-Q Quarterly report Nov 3, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 2, 2021 Nov 2, 2021
8-K Current report
Material agreement
Aug 9, 2021 Aug 9, 2021
424B2 Prospectus Aug 6, 2021 —
FWP Free writing prospectus Aug 6, 2021 —
424B3 Prospectus Aug 5, 2021 —
10-Q Quarterly report Aug 4, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 3, 2021 Aug 3, 2021
8-K Current report
Officer or director change
Jul 30, 2021 Jul 29, 2021
8-K Current report
Material agreement, Regulation FD disclosure
Jul 27, 2021 Jul 27, 2021
11-K Employee savings plan report Jun 23, 2021 Dec 31, 2020
11-K Employee savings plan report Jun 23, 2021 Dec 31, 2020
8-K Current report
Material agreement, Regulation FD disclosure
Jun 1, 2021 Jun 1, 2021
8-K Current report
Shareholder vote results
May 19, 2021 May 18, 2021
DEFA14A Additional proxy material Apr 30, 2021 —
DEFA14A Additional proxy material Apr 28, 2021 —
10-Q Quarterly report Apr 28, 2021 Mar 31, 2021
8-K Current report
Results of operations
Apr 27, 2021 Apr 27, 2021
SC TO-T/A Filing Apr 16, 2021 —
8-K Current report
Acquisition or sale of assets, Regulation FD disclosure
Apr 16, 2021 Apr 16, 2021
EFFECT Filing Apr 15, 2021 —
424B3 Prospectus Apr 15, 2021 —
DEFA14A Additional proxy material Apr 14, 2021 —
CORRESP Letter to the SEC Apr 13, 2021 —
SC TO-T/A Filing Apr 8, 2021 —
S-4/A Filing Apr 6, 2021 —
DEFA14A Additional proxy material Apr 6, 2021 —
DEF 14A Proxy statement Apr 6, 2021 May 18, 2021
SC TO-T/A Filing Apr 6, 2021 —
SC TO-T/A Filing Mar 22, 2021 —
SC TO-T Filing Mar 18, 2021 —
SC TO-C Filing Mar 5, 2021 —
SC TO-C Filing Mar 4, 2021 —
SC TO-C Filing Mar 4, 2021 —
8-K Current report
Material agreement, Regulation FD disclosure
Mar 4, 2021 Mar 4, 2021
UPLOAD Letter from the SEC Feb 18, 2021 —
CORRESP Letter to the SEC Feb 9, 2021 —
S-4 Registration for a merger or exchange Feb 9, 2021 —
10-K Annual report Feb 9, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 2, 2021 Feb 2, 2021
25 Filing Dec 28, 2020 —
CERT Filing Dec 28, 2020 —
8-A12B Filing Dec 28, 2020 —
10-Q Quarterly report Oct 29, 2020 Sep 30, 2020
8-K Current report
Results of operations
Oct 28, 2020 Oct 28, 2020
8-K Current report
Material agreement
Aug 18, 2020 Aug 17, 2020
8-K Current report
Other events
Aug 14, 2020 Aug 13, 2020
8-K Current report
Other events
Jul 30, 2020 Jul 30, 2020
10-Q Quarterly report Jul 29, 2020 Jun 30, 2020
8-K Current report
Results of operations
Jul 28, 2020 Jul 28, 2020
8-K Current report
Officer or director change
Jul 23, 2020 Jul 23, 2020
8-K Current report
Officer or director change
Jul 23, 2020 Jul 22, 2020
11-K Employee savings plan report Jun 17, 2020 Dec 31, 2019
11-K Employee savings plan report Jun 17, 2020 Dec 31, 2019
8-K Current report
Shareholder vote results
May 20, 2020 May 19, 2020
8-K Current report
Material agreement
May 6, 2020 May 6, 2020
424B2 Prospectus May 6, 2020 —
FWP Free writing prospectus May 5, 2020 —
424B3 Prospectus May 4, 2020 —
10-Q Quarterly report May 1, 2020 Mar 31, 2020
8-K Current report
Results of operations
Apr 30, 2020 Apr 30, 2020
DEFA14A Additional proxy material Apr 29, 2020 —
DEFA14A Additional proxy material Apr 29, 2020 —
PX14A6G Filing Apr 15, 2020 —
DEFA14A Additional proxy material Apr 13, 2020 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
AMGN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Thousand Oaks, CA
SEC filer status
Large accelerated filer
SEC CIK
318154

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.